IHS Chemical Week

EnviroTech :: Biotech

Novozymes Sales and Profits Grow Strongly in 2010

4:44 AM MST | January 24, 2011 | Alex Scott

Enzymes technology company Novozymes (Copenhagen) says its 2010 Ebit increased 25% to DK 2.1 billion ($382 million) on sales up 15% to DK 9.7 billion. Overall demand was high in the enzyme business, and costs were kept under control, the company says.   The outlook for 2011 is for an Ebit growth of 8-11% with a corresponding growth in sales of 7-11%. ROIC was 22.2% in 2010, compared with 20.3% in 2009, including goodwill.   “We performed very well in terms of sales, earnings, cash flow, and sustainability," says Steen Riisgaard...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa